- Home
- UYSC vs NVNO Comparison
UYSC vs NVNO Comparison
Compare UYSC & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UYSC
- NVNO
- Stock Information
- Founded
- UYSC 2024
- NVNO 1987
- Country
- UYSC United States
- NVNO United States
- Employees
- UYSC N/A
- NVNO N/A
- Industry
- UYSC Blank Checks
- NVNO Medical/Dental Instruments
- Sector
- UYSC Finance
- NVNO Health Care
- Exchange
- UYSC Nasdaq
- NVNO Nasdaq
- Market Cap
- UYSC 76.5M
- NVNO 71.0M
- IPO Year
- UYSC 2025
- NVNO N/A
- Fundamental
- Price
- UYSC $10.08
- NVNO $4.98
- Analyst Decision
- UYSC
- NVNO
- Analyst Count
- UYSC 0
- NVNO 0
- Target Price
- UYSC N/A
- NVNO N/A
- AVG Volume (30 Days)
- UYSC 2.7K
- NVNO 137.8K
- Earning Date
- UYSC 01-01-0001
- NVNO 08-08-2025
- Dividend Yield
- UYSC N/A
- NVNO N/A
- EPS Growth
- UYSC N/A
- NVNO N/A
- EPS
- UYSC N/A
- NVNO N/A
- Revenue
- UYSC N/A
- NVNO N/A
- Revenue This Year
- UYSC N/A
- NVNO N/A
- Revenue Next Year
- UYSC N/A
- NVNO N/A
- P/E Ratio
- UYSC N/A
- NVNO N/A
- Revenue Growth
- UYSC N/A
- NVNO N/A
- 52 Week Low
- UYSC $10.05
- NVNO $2.03
- 52 Week High
- UYSC $11.00
- NVNO $5.92
- Technical
- Relative Strength Index (RSI)
- UYSC N/A
- NVNO 63.64
- Support Level
- UYSC N/A
- NVNO $4.65
- Resistance Level
- UYSC N/A
- NVNO $5.27
- Average True Range (ATR)
- UYSC 0.00
- NVNO 0.38
- MACD
- UYSC 0.00
- NVNO 0.05
- Stochastic Oscillator
- UYSC 0.00
- NVNO 64.90
About UYSC UY Scuti Acquisition Corp. Ordinary Shares
UY Scuti Acquisition Corp is a newly organized blank check company.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.